Gloviczki P, Pairolero P C, Toomey B J, Bower T C, Rooke T W, Stanson A W, Hallett J W, Cherry K J
Division of Vascular Surgery, Mayo Clinic, Rochester, MN 55905.
J Vasc Surg. 1992 Nov;16(5):750-61.
To evaluate the effectiveness of venous grafting, we reviewed the management and clinical course of 28 patients (21 males and seven females) who underwent 29 reconstructions of large veins for benign disease. There were 12 patients with superior vena cava (SVC) syndrome, two with subclavian vein thrombosis, and 15 with occlusion of the inferior vena cava (IVC) or iliac veins. One of these patients underwent both IVC and SVC reconstructions. Reconstruction of the SVC was performed with spiral saphenous vein graft (SSVG) in nine patients and expanded polytetrafluoroethylene (ePTFE) in three. All seven straight SSVGs had documented patency at a median of 7 months (2 weeks to 5 years) after reconstruction. Six patients had complete relief of symptoms. Two patients with bifurcated SSVG had early occlusion of one graft limb. Two of the three ePTFE grafts needed early thrombectomy. One graft reoccluded at 6 months and two were patent at 2 and 5 years. The two subclavian vein reconstructions with axillary-jugular ePTFE grafts with an arteriovenous fistula had documented early patency. Both patients had rapid resolution of symptoms. The IVC or iliac vein was reconstructed with ePTFE graft in 11 patients, SSVG in three, and Dacron in one. A femorofemoral arteriovenous fistula was added in eight patients with ePTFE grafts. Seven of the 11 ePTFE grafts had documented patency at the last follow-up (median 9 months; range 2 weeks to 5 years). None of the three SSVGs had documented long-term patency. The one Dacron cavoatrial graft occluded at 3 years. A straight SSVG continues to be our first choice for SVC replacement. Short, large-diameter ePTFE grafts perform the best in the abdomen. Femorocaval or long iliocaval grafts need an arteriovenous fistula to maintain patency. Long-term patency after closure of the fistula is still unknown. Femorocaval grafts with poor venous inflow have limited chance of success. Failed or failing grafts may be salvaged by early thrombectomy. Venous reconstruction to treat selected patients with symptoms with large vein occlusion continues to be a viable option.
为评估静脉移植的有效性,我们回顾了28例(21例男性和7例女性)因良性疾病接受29次大静脉重建手术患者的治疗情况及临床病程。其中有12例上腔静脉(SVC)综合征患者,2例锁骨下静脉血栓形成患者,以及15例下腔静脉(IVC)或髂静脉闭塞患者。这些患者中有1例同时接受了IVC和SVC重建手术。9例患者采用螺旋大隐静脉移植物(SSVG)进行SVC重建,3例采用膨体聚四氟乙烯(ePTFE)。所有7条直形SSVG在重建后中位时间7个月(2周至5年)时均记录为通畅。6例患者症状完全缓解。2例采用分叉SSVG的患者,其中一个移植肢体早期闭塞。3例ePTFE移植物中有2例需要早期进行血栓切除术。1例移植物在6个月时再次闭塞,2例在2年和5年时保持通畅。2例采用带动静脉瘘的腋 - 颈ePTFE移植物进行锁骨下静脉重建的患者,早期记录为通畅。2例患者症状均迅速缓解。11例患者采用ePTFE移植物重建IVC或髂静脉,3例采用SSVG,1例采用涤纶。8例接受ePTFE移植物的患者加做了股 - 股动静脉瘘。11例ePTFE移植物中有7例在最后一次随访时记录为通畅(中位时间9个月;范围2周至5年)。3条SSVG均无长期通畅的记录。1条涤纶腔房移植物在3年时闭塞。直形SSVG仍然是我们进行SVC置换的首选。短的、大直径的ePTFE移植物在腹部表现最佳。股腔或长段髂腔移植物需要动静脉瘘来维持通畅。瘘关闭后的长期通畅情况仍不清楚。静脉流入不良的股腔移植物成功机会有限。失败或即将失败的移植物可通过早期血栓切除术挽救。对于有症状的大静脉闭塞的特定患者,静脉重建仍然是一个可行的选择。